ABCL

AbCellera Biologics Inc. Common Shares

3.90

USD

ABCL Earnings Reports

Positive Surprise Ratio

ABCL beat 8 of 20 last estimates.

40%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

$5.75M

-$0.18

Implied change from Q3 25 (Revenue/ EPS)

-35.75%

-5.26%

Implied change from Q4 24 (Revenue/ EPS)

+13.94%

+63.64%

AbCellera Biologics Inc. Common Shares earnings per share and revenue

On Nov 06, 2025, ABCL reported earnings of -0.19 USD per share (EPS) for Q3 25, missing the estimate of -0.17 USD, resulting in a -10.40% surprise. Revenue reached 8.96 million, compared to an expected 6.03 million, with a 48.57% difference. The market reacted with a -13.69% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.18 USD, with revenue projected to reach 5.75 million USD, implying an decrease of -5.26% EPS, and decrease of -35.75% in Revenue from the last quarter.

FAQ

What were AbCellera Biologics Inc. Common Shares's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, AbCellera Biologics Inc. Common Shares reported EPS of -$0.19, missing estimates by -10.4%, and revenue of $8.96M, 48.57% above expectations.

How did the market react to AbCellera Biologics Inc. Common Shares's Q3 2025 earnings?

The stock price moved down -13.69%, changed from $4.53 before the earnings release to $3.91 the day after.

When is AbCellera Biologics Inc. Common Shares expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for AbCellera Biologics Inc. Common Shares's next earnings report?

Based on 10 analysts, AbCellera Biologics Inc. Common Shares is expected to report EPS of -$0.18 and revenue of $5.75M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.